LONDON, 16 October, 2013 - Panmure Gordon & Co, a leading independent institutional stockbroker and investment bank, is pleased to advise that it has acted as Nominated Adviser and sole broker on the IPO of Kromek Group plc (KMK.L) raising £15m. Kromek was incorporated in April 2003 in order to commercialise technology related to the development and manufacture of cadmium zinc telluride (CZT) and related materials for the medical, security screening and nuclear markets which had been developed over a period of approximately 20 years in the Physics Department of Durham University, UK. The proceeds of the fundraising will be used for product development, expansion of the sales and marketing team, investment into the Company's intellectual property portfolio, capital expenditure to support future growth and manufacturing capability, working capital and strengthening the balance sheet, including paying down outstanding loans.